Immediate Impact

59 standout
Sub-graph 1 of 18

Citing Papers

Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
2024 Standout
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
2023 Standout
2 intermediate papers

Works of K. Kerlin being referenced

A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)
2012

Author Peers

Author Last Decade Papers Cites
K. Kerlin 75 22 20 24 11 111
Xiufang Tian 48 30 20 24 11 122
N. Antoniou 60 4 8 12 15 114
Francesco Jacopo Romano 88 27 44 41 13 193
Jacqueline Lam 79 16 36 20 7 122
E. Meyer 111 43 17 22 16 134
Randi A. Schea 60 39 18 14 8 147
Julia Maués 81 6 15 25 13 169
Shivani Sud 23 19 23 9 10 122
Brock R. Baker 133 33 57 45 11 222
Evgeny Sadikov 90 14 13 40 16 174

All Works

Loading papers...

Rankless by CCL
2026